Eli Lilly and Company (LLY)
NYSE · Healthcare
Eli Lilly and Company Operating Income 2020–2025
Eli Lilly and Company annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Eli Lilly and Company operating income for the quarter ending March 31, 2026 was 9.8 B, a 84.43% increase year-over-year.
- Eli Lilly and Company operating income for the twelve months ending March 31, 2026 was 34.2 B.
- Eli Lilly and Company annual operating income for 2025 was 29.7 B, a 74.27% increase from 2024.
- Eli Lilly and Company annual operating income for 2024 was 17.0 B, a 57.96% increase from 2023.
- Eli Lilly and Company annual operating income for 2023 was 10.8 B, a 24.66% increase from 2022.
- Eli Lilly and Company annual operating income for 2022 was 8.7 B.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Eli Lilly and Company Operating Income — FAQ
Eli Lilly and Company (LLY) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Eli Lilly and Company's operating income?
Eli Lilly and Company (LLY) reported operating income of $29.70B for fiscal 2025.
Where can I see LLY's operating income history?
The chart and table above show Eli Lilly and Company's operating income by year and by quarter, including the growth rate.